作者
Hao Liu, Wei Zhang, Mengyang Di, Hang Lee, Ruy Cruz, Xixi Wang, Christof Kaltenmeier, Ann M Thompson, Dheera Reddy, Eishan Ashwat, Mark D'Alesio, Steven Lebowitz, Samer Tohme, David A Geller, Amit D Tevar, Christopher Hughes, Abhinav Humar, Jaideep Behari, Ramon Bataller, Michele Molinari
发表日期
2022/5/1
期刊
Gastroenterology
卷号
162
期号
7
页码范围
S-1198
出版商
WB Saunders
简介
AASLDA b st ra ct s Fig. 2: Survival function of subgroup analyses of short waiting time population (A.) and long waiting time population (B.) estimated by Weibull model Su1376 HIGHER HEPATOCELLULAR CARCINOMA TUMOR BURDEN SCORE IS ASSOCIATED WITH GREATER LIVER TRANSPLANT SURVIVAL BENEFIT Hao Liu, Wei Zhang, Mengyang Di, Hang Lee, Ruy Cruz, Xixi Wang, Christof Kaltenmeier, Ann M. Thompson, Dheera Reddy, Eishan Ashwat, Mark D'Alesio, Steven Lebowitz, Samer Tohme, David A. Geller, Amit D. Tevar, Christopher Hughes, Abhinav Humar, Jaideep Behari, Ramon Bataller, Michele Molinari Introduction Liver transplantation (LT) is the best treatment option for early-stage hepatocel-lular carcinoma (HCC) and cirrhosis. However, patients with various tumor burdens receive identical listing priority, despite the strong correlation between higher tumor burden and greater waitlist …
引用总数
学术搜索中的文章